Style | Citing Format |
---|---|
MLA | Daneshtalab A, et al.. "Intravitreal Stivant® (A Biosimilar to Bevacizumab) Alone Versus Combined With Triamcinolone in Center-Involved Diabetic Macular Edema." JFO Open Ophthalmology, vol. 11, no. , 2025, pp. -. |
APA | Daneshtalab A, Shekofteh M, Fathizadeh H, Rajabi MT, Rafizadeh SM, Aghajani A, Esfandiarifard S, Akbari Z, Sardarinia M, Jamalipour Soufi K, Zand A (2025). Intravitreal Stivant® (A Biosimilar to Bevacizumab) Alone Versus Combined With Triamcinolone in Center-Involved Diabetic Macular Edema. JFO Open Ophthalmology, 11(), -. |
Chicago | Daneshtalab A, Shekofteh M, Fathizadeh H, Rajabi MT, Rafizadeh SM, Aghajani A, Esfandiarifard S, et al.. "Intravitreal Stivant® (A Biosimilar to Bevacizumab) Alone Versus Combined With Triamcinolone in Center-Involved Diabetic Macular Edema." JFO Open Ophthalmology 11, no. (2025): -. |
Harvard | Daneshtalab A et al. (2025) 'Intravitreal Stivant® (A Biosimilar to Bevacizumab) Alone Versus Combined With Triamcinolone in Center-Involved Diabetic Macular Edema', JFO Open Ophthalmology, 11(), pp. -. |
Vancouver | Daneshtalab A, Shekofteh M, Fathizadeh H, Rajabi MT, Rafizadeh SM, Aghajani A, et al.. Intravitreal Stivant® (A Biosimilar to Bevacizumab) Alone Versus Combined With Triamcinolone in Center-Involved Diabetic Macular Edema. JFO Open Ophthalmology. 2025;11():-. |
BibTex | @article{ author = {Daneshtalab A and Shekofteh M and Fathizadeh H and Rajabi MT and Rafizadeh SM and Aghajani A and Esfandiarifard S and Akbari Z and Sardarinia M and Jamalipour Soufi K and Zand A}, title = {Intravitreal Stivant® (A Biosimilar to Bevacizumab) Alone Versus Combined With Triamcinolone in Center-Involved Diabetic Macular Edema}, journal = {JFO Open Ophthalmology}, volume = {11}, number = {}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Daneshtalab A AU - Shekofteh M AU - Fathizadeh H AU - Rajabi MT AU - Rafizadeh SM AU - Aghajani A AU - Esfandiarifard S AU - Akbari Z AU - Sardarinia M AU - Jamalipour Soufi K AU - Zand A TI - Intravitreal Stivant® (A Biosimilar to Bevacizumab) Alone Versus Combined With Triamcinolone in Center-Involved Diabetic Macular Edema JO - JFO Open Ophthalmology VL - 11 IS - SP - EP - PY - 2025 ER - |